JETEMA, Co., Ltd. (KOSDAQ:216080)

South Korea flag South Korea · Delayed Price · Currency is KRW
8,650.00
+130.00 (1.53%)
At close: Mar 20, 2026
Market Cap315.74B +34.5%
Revenue (ttm)75.55B +16.8%
Net Income-4.36B
EPS-121.79
Shares Out36.50M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume207,353
Average Volume409,391
Open8,520.00
Previous Close8,520.00
Day's Range8,370.00 - 8,690.00
52-Week Range5,370.00 - 11,280.00
Beta0.94
RSI46.58
Earnings DateMar 24, 2026

About JETEMA,

JETEMA, Co., Ltd., a bio venture company, engages in the research and development of medicines and medical devices. It offers clostridium botulinum toxins, fillers, lifting threads for medical treatment, elastin and collagen stimulate solution under Ecolla, and healthy skin care under vitten brand names. The company also provides skin care hyaluronic acid masks. JETEMA, Co., Ltd. was founded in 2009 and is headquartered in Wonju-si, South Korea. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2009
Employees 265
Stock Exchange KOSDAQ
Ticker Symbol 216080
Full Company Profile

Financial Performance

Financial Statements